Premium
Lateral Flow Glyco‐Assays for the Rapid and Low‐Cost Detection of Lectins–Polymeric Linkers and Particle Engineering Are Essential for Selectivity and Performance
Author(s) -
Baker Alexander N.,
Muguruza Asier R.,
Richards SarahJane,
Georgiou Panagiotis G.,
Goetz Stephen,
Walker Marc,
Dedola Simone,
Field Robert A.,
Gibson Matthew I.
Publication year - 2022
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.202101784
Subject(s) - biosensor , glycan , analyte , nanoparticle , nanotechnology , polymer , materials science , molecularly imprinted polymer , chemistry , selectivity , chromatography , biochemistry , glycoprotein , organic chemistry , catalysis
Abstract Lateral flow immuno‐assays, such as the home pregnancy test, are rapid point‐of‐care diagnostics that use antibody‐coated nanoparticles to bind antigens/analytes (e.g., viruses, toxins or hormones). Ease of use, no need for centralized infrastructure and low‐cost, makes these devices appealing for rapid disease identification, especially in low‐resource environments. Here glycosylated polymer‐coated nanoparticles are demonstrated for the sensitive, label‐free detection of lectins in lateral flow and flow‐through. The systems introduced here use glycans, not antibodies, to provide recognition: a “lateral flow glyco‐assay,” providing unique biosensing opportunities. Glycans are installed onto polymer termini and immobilized onto gold nanoparticles, providing colloidal stability but crucially also introducing assay tunability and selectivity. Using soybean agglutinin and Ricinus communis agglutinin I (RCA 120 ) as model analytes, the impact of polymer chain length and nanoparticle core size are evaluated, with chain length found to have a significant effect on signal generation—highlighting the need to control the macromolecular architecture to tune response. With optimized systems, lectins are detectable at subnanomolar concentrations, comparable to antibody‐based systems. Complete lateral flow devices are also assembled to show how these devices can be deployed in the “real world.” This work shows that glycan‐binding can be a valuable tool in rapid diagnostics.